COVID-19 drug practices risk antimicrobial resistance evolution

Lancet Microbe. 2021 Apr;2(4):e135-e136. doi: 10.1016/S2666-5247(21)00039-2. Epub 2021 Feb 24.
No abstract available

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • COVID-19 Drug Treatment*
  • Drug Resistance, Bacterial
  • Humans
  • SARS-CoV-2

Substances

  • Anti-Bacterial Agents